• UCLA Health
  • myUCLAhealth
  • School of Medicine
CORE Kidney

CORE Kidney Program

CORE Kidney
  • About Us
    • Director's Welcome
    • In the News
    • Photo Gallery
  • Clinical Programs
    • About the Clinical Research Program
    • Alport Syndrome
    • Chronic Kidney Disease (CKD)
    • Diabetic Kidney Disease
    • ESRD | Dialysis
    • Fabry's Disease
    • Glomerulonephritis Program
    • Hypertension
    • Kidney Stone Program
    • Living Kidney Donor
    • Music Program
    • OncoNephrology (Kidney Disease in Cancer Patients)
    • PKD Center
    • Peritoneal Dialysis (PD)
    • Transplant Research and Education Center
    • Urinary Tract Infection (UTI)
  • Webinars
  • Outreach
    • Green Ribbon Spotlights
    • Upcoming Events
    • Kidney Fair
    • UKEEP
  • Our Expert Team
    • Bruin Beans
    • Our Ambassadors
    • Post-Doc Fellows
  • Make a Gift
    • Monetary Donations and Philanthropy
    • Volunteer Your Time
    • Register to be an Organ Donor
    • Become a Living Organ Donor
  • Patient Resources
    • Conditions Treated
    • Our Locations
    • Make an Appointment
    • Education
    • Patient Stories
    • Ask the Experts
    • Support Groups
    • Other Resources
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

CORE Kidney Program

PKD Center

PKD Center

PKD Center

  • Director's Welcome
  • Facilities
  • PKD Research
  • PKD Information
    • Diagnosis of PKD
      • Imaging Tests
    • Disease Associations
    • Genetics
    • Nutrition
    • Pathophysiology of PKD
    • Pediatric PKD
    • PKD and the Liver
    • PKD and Pregnancy
    • Webinars
  • Patient Stories
  • Support Groups
  • Director's Welcome
  • Facilities
  • PKD Research
  • PKD Information
  • Patient Stories
  • Support Groups
  1. Home
  2. Clinical Programs
  3. PKD Center
  4. PKD Research

PKD Research

Share this

What are Clinical Trials?

♦ Learn More About Clinical Trials

 


Current Studies at UCLA

Tesevatinib

A Double-blind Randomized Parallel Group Study of the Efficacy and Safety of Tesevatinib in Subjects with Autosomal Dominant Polycystic Kidney Disease. The primary outcome measures are to change the height adjusted total kidney volume in ADPKD patient in two year time period. 

♦ Click here for more information about Tesevatinib in Subjects with ADPKD

A Phase 1b/2a, Safety, Pharmacokinetic and Dose-Escalation Study of KD019 in Subjects with Autosomal Dominant Polycystic Kidney Disease. The primary outcome is to analysis a two year time period of change in glomerular filtration rate (GFR) in ADPKD patients.

♦ Click here for more information about Subjects with ADPKD

 

Tolvaptan

A Phase 3b, Multi-center, Open-label Trial to Evaluate the Long -Term Safety of Titrated Immediate-release Tolvaptan (OPC 41061, 30 mg to 120 mg/Day, Split Dose) in Subjects with Autosomal Dominant Polycystic Kidney Disease. The primary outcome is to determine the long-term safety of Tolvaptan in ADPKD patients. 

♦ Click here for more information about Tolvaptan in Subjects with ADPKD


Completed Studies at UCLA

Tolvaptan

A Phase 3, Multi-center, Double-blind, Placebo-controlled, Parallel-arm Trial to Determine Long-term Safety and Efficacy of Oral Tolvaptan Tablets Regimens in Adult Subjects With Autosomal Dominant Polycystic Kidney Disease

♦ Click here for more information about Tolvaptan in Subjects with ADPKD

A Phase 3b, Multi-center, Randomized-withdrawal, Placebo-controlled, Double-blind, Parallel-group Trial to Compare the Efficacy and Safety of Tolvaptan (45 to 120 mg/Day, Split-dose) in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease

♦ Click here for more information about Tolvaptan in Subjects with ADPKD

 

Overture

A Multi-center, Longitudinal, Observational Study of Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) to Establish the Rate, Characteristics, and Determinants of Disease Progression

♦ Click here for more information about this study


If you are interested in participating in a PKD Trial, please contact (310) 825-7919 or email PKD@mednet.ucla.edu.

For all general questions and information, please contact (310) 954-2692 or email COREKidney@mednet.ucla.edu.

Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-800-UCLA-MD1
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth